Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer.
Conte, P F, Baldini, E, Gennari, A, Michelotti, A, Salvadori, B, Tibaldi, C, Danesi, R, Innocenti, F, Gentile, A, Dell'Anna, R, Biadi, O, Mariani, M, Del Tacca, MVolume:
15
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.1997.15.7.2510
Date:
July, 1997
File:
PDF, 664 KB
1997